Nasiell K, Roger V, Nasiell M
Obstet Gynecol. 1986 May;67(5):665-9. doi: 10.1097/00006250-198605000-00012.
Five hundred and fifty-five women with cervical cytologically diagnosed mild cervical dysplasia were followed by cytology without major treatment. Biopsies were performed in 14% resulting in no significant influence on the outcome of the studied material. Regression to normal occurred in 62% (follow-up 39 months), progression to severe dysplasia/carcinoma in situ/invasive carcinoma in 16% (invasive carcinoma: two patients), and persistence of dysplasia in 22%. Life table analysis calculated the risk of progression of mild dysplasia to be 250 to 800/100,000 women/year. A comparison with the incidence of carcinoma in situ, four of 100,000 women/year, illustrates the yearly risk for a woman with mild dysplasia as 560 times greater than for a woman without cervical dysplasia to develop severe dysplasia/carcinoma in situ/invasive carcinoma.
555名经宫颈细胞学诊断为轻度宫颈发育异常的女性在未接受主要治疗的情况下接受了细胞学随访。14%的患者进行了活检,对所研究材料的结果没有显著影响。62%的患者恢复正常(随访39个月),16%的患者进展为重度发育异常/原位癌/浸润性癌(浸润性癌:2例患者),22%的患者发育异常持续存在。生命表分析计算出轻度发育异常进展的风险为每100,000名女性每年250至800例。与原位癌的发病率(每年每100,000名女性中有4例)相比,说明轻度发育异常女性每年发生重度发育异常/原位癌/浸润性癌的风险是无宫颈发育异常女性的560倍。